VERVE THERAPEUTICS, INC. (NASDAQ: VERV) INVESTOR ALERT: Investors With Large Losses in Verve Therapeutics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the "Class") who purchased or acquired the securities of Verve Therapeutics, Inc. ("Verve Therapeutics" or the "Company") (NASDAQ: VERV) between August 9, 2022 and April 1, 2024, inclusive (the "Class Period"). For more information, submit a form at Verve Therapeutics, Inc. Shareholder Class Action Lawsuit, email Investor Relations Manager Peter ...